Jixian Wang is a statistical methodologist in Bristol Myers Squibb, Switzerland. He has worked on drug development for over twenty years and was an academic researcher before joining the pharmaceutical industry. His research interests include statistical methodology and its applications to real problems in pharmaceuticals, including exposure-safety, PKPD modeling, treatment/dose selection, health economics, benefit-risk and health technology assessments, and optimal trial design with 60+ publications on peer-reviewed journals.